Syringes - ANVISA Registration 80102519342
Access comprehensive regulatory information for Syringes in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102519342 and manufactured by SHENZHEN ANTMED CO.,LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including UNION MEDICAL SHENZHEN CO., LTD, MEDTRON AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80102519342
25351098005202571
04718143000194
Company Information
Dates and Status
Jun 30, 2025
VIGENTE
09/18/2025 19:00:01
Syringes
Família Day Safe Syringes
MEDTRON AG
80047309197
Feb 13, 2023
Syringes
Kit Multi-paciente
SHENZHEN ANTMED CO.,LTD.
80102519337
Jun 09, 2025
Syringes
SERINGA ELS
MEDTRON AG
10061409001
Nov 23, 2009
Syringes
KIT SERINGA CMW
DEPUY (IRELAND) LTD.
80145901067
Jan 21, 2008
Syringes
KIT SERINGA CMW
DePuy International Ltd Trading as DePuy CMW
80145901067
Jan 21, 2008
Seringas
Seringas Preenchidas OLIFLUSH
Not specified
80273450062
Sep 08, 2025
Seringas
Seringas Preenchidas OLIFLUSH
ZHEJIANG HOPE PHARMA CO., LTD.
80273450062
Sep 08, 2025
Seringas
SERINGA NANUM
NANUM COMPANY CO., LTD.
80886739002
Jul 28, 2025
Seringas
Kit Multi-paciente
SHENZHEN ANTMED CO.,LTD.
80102519337
Jun 09, 2025
Seringas
Sistema de Seringa Multi-paciente
SHENZHEN ANTMED CO.,LTD.
80102519323
May 05, 2025